NFIL3_HUMAN - dbPTM
NFIL3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NFIL3_HUMAN
UniProt AC Q16649
Protein Name Nuclear factor interleukin-3-regulated protein
Gene Name NFIL3
Organism Homo sapiens (Human).
Sequence Length 462
Subcellular Localization Nucleus .
Protein Description Acts as a transcriptional regulator that recognizes and binds to the sequence 5'-[GA]TTA[CT]GTAA[CT]-3', a sequence present in many cellular and viral promoters. Represses transcription from promoters with activating transcription factor (ATF) sites. Represses promoter activity in osteoblasts (By similarity). Represses transcriptional activity of PER1 (By similarity). Represses transcriptional activity of PER2 via the B-site on the promoter (By similarity). Activates transcription from the interleukin-3 promoter in T-cells. Competes for the same consensus-binding site with PAR DNA-binding factors (DBP, HLF and TEF) (By similarity). Component of the circadian clock that acts as a negative regulator for the circadian expression of PER2 oscillation in the cell-autonomous core clock (By similarity). Protects pro-B cells from programmed cell death (By similarity)..
Protein Sequence MQLRKMQTVKKEQASLDASSNVDKMMVLNSALTEVSEDSTTGEELLLSEGSVGKNKSSACRRKREFIPDEKKDAMYWEKRRKNNEAAKRSREKRRLNDLVLENKLIALGEENATLKAELLSLKLKFGLISSTAYAQEIQKLSNSTAVYFQDYQTSKSNVSSFVDEHEPSMVSSSCISVIKHSPQSSLSDVSEVSSVEHTQESSVQGSCRSPENKFQIIKQEPMELESYTREPRDDRGSYTASIYQNYMGNSFSGYSHSPPLLQVNRSSSNSPRTSETDDGVVGKSSDGEDEQQVPKGPIHSPVELKHVHATVVKVPEVNSSALPHKLRIKAKAMQIKVEAFDNEFEATQKLSSPIDMTSKRHFELEKHSAPSMVHSSLTPFSVQVTNIQDWSLKSEHWHQKELSGKTQNSFKTGVVEMKDSGYKVSDPENLYLKQGIANLSAEVVSLKRLIATQPISASDSG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
11AcetylationRKMQTVKKEQASLDA
CCCHHHCHHHHCCCC
51.2026051181
19PhosphorylationEQASLDASSNVDKMM
HHHCCCCCCCHHHHH
23.3225627689
20PhosphorylationQASLDASSNVDKMMV
HHCCCCCCCHHHHHH
42.4625627689
24SumoylationDASSNVDKMMVLNSA
CCCCCHHHHHHHHHH
25.3128112733
30PhosphorylationDKMMVLNSALTEVSE
HHHHHHHHHHEECCC
22.09-
72SumoylationEFIPDEKKDAMYWEK
CCCCHHHHHHHHHHH
48.98-
72SumoylationEFIPDEKKDAMYWEK
CCCCHHHHHHHHHHH
48.98-
82AcetylationMYWEKRRKNNEAAKR
HHHHHHHHCCHHHHH
69.067910691
82SumoylationMYWEKRRKNNEAAKR
HHHHHHHHCCHHHHH
69.06-
104UbiquitinationNDLVLENKLIALGEE
HHHHHHHHHHHHCCC
31.71-
116UbiquitinationGEENATLKAELLSLK
CCCCHHHHHHHHHHH
35.15-
121PhosphorylationTLKAELLSLKLKFGL
HHHHHHHHHHHHHCC
35.7624719451
152PhosphorylationTAVYFQDYQTSKSNV
CEEEEECHHCCCCCH
11.6929759185
154PhosphorylationVYFQDYQTSKSNVSS
EEEECHHCCCCCHHH
31.7129759185
155PhosphorylationYFQDYQTSKSNVSSF
EEECHHCCCCCHHHH
20.6829759185
182PhosphorylationCISVIKHSPQSSLSD
HHHHHCCCCCCCCCC
21.4520873877
185PhosphorylationVIKHSPQSSLSDVSE
HHCCCCCCCCCCCCC
36.3120873877
186PhosphorylationIKHSPQSSLSDVSEV
HCCCCCCCCCCCCCC
27.0120873877
199PhosphorylationEVSSVEHTQESSVQG
CCCCCEECCCCCCCC
22.1128348404
202PhosphorylationSVEHTQESSVQGSCR
CCEECCCCCCCCCCC
26.4529116813
203PhosphorylationVEHTQESSVQGSCRS
CEECCCCCCCCCCCC
20.0829116813
207PhosphorylationQESSVQGSCRSPENK
CCCCCCCCCCCCCCC
6.8330576142
210PhosphorylationSVQGSCRSPENKFQI
CCCCCCCCCCCCEEE
40.6730576142
214SumoylationSCRSPENKFQIIKQE
CCCCCCCCEEEEECC
36.6628112733
219SumoylationENKFQIIKQEPMELE
CCCEEEEECCCCCHH
50.68-
219SumoylationENKFQIIKQEPMELE
CCCEEEEECCCCCHH
50.6825114211
242PhosphorylationDRGSYTASIYQNYMG
CCCCCEEEEEHHHCC
17.6527080861
247PhosphorylationTASIYQNYMGNSFSG
EEEEEHHHCCCCCCC
7.2927080861
251PhosphorylationYQNYMGNSFSGYSHS
EHHHCCCCCCCCCCC
18.3027080861
253PhosphorylationNYMGNSFSGYSHSPP
HHCCCCCCCCCCCCC
36.3227080861
255PhosphorylationMGNSFSGYSHSPPLL
CCCCCCCCCCCCCEE
11.3027080861
256PhosphorylationGNSFSGYSHSPPLLQ
CCCCCCCCCCCCEEE
22.4827080861
258PhosphorylationSFSGYSHSPPLLQVN
CCCCCCCCCCEEECC
23.4419276368
267PhosphorylationPLLQVNRSSSNSPRT
CEEECCCCCCCCCCC
32.6830576142
268PhosphorylationLLQVNRSSSNSPRTS
EEECCCCCCCCCCCC
30.2427732954
269PhosphorylationLQVNRSSSNSPRTSE
EECCCCCCCCCCCCC
42.4430576142
271PhosphorylationVNRSSSNSPRTSETD
CCCCCCCCCCCCCCC
20.0827732954
274PhosphorylationSSSNSPRTSETDDGV
CCCCCCCCCCCCCCC
34.0130576142
275PhosphorylationSSNSPRTSETDDGVV
CCCCCCCCCCCCCCC
39.5223927012
277PhosphorylationNSPRTSETDDGVVGK
CCCCCCCCCCCCCCC
38.8728450419
285PhosphorylationDDGVVGKSSDGEDEQ
CCCCCCCCCCCCCCC
27.9423401153
286PhosphorylationDGVVGKSSDGEDEQQ
CCCCCCCCCCCCCCC
53.7925159151
301PhosphorylationVPKGPIHSPVELKHV
CCCCCCCCCCCCCEE
31.2129255136
306SumoylationIHSPVELKHVHATVV
CCCCCCCCEEEEEEE
30.03-
306SumoylationIHSPVELKHVHATVV
CCCCCCCCEEEEEEE
30.0328112733
311PhosphorylationELKHVHATVVKVPEV
CCCEEEEEEEECCCC
15.7923312004
314SumoylationHVHATVVKVPEVNSS
EEEEEEEECCCCCCC
47.9728112733
326SumoylationNSSALPHKLRIKAKA
CCCCCCCHHHHCEEE
37.2128112733
332SumoylationHKLRIKAKAMQIKVE
CHHHHCEEEEEEEEE
39.1128112733
337SumoylationKAKAMQIKVEAFDNE
CEEEEEEEEEECCCC
19.68-
337SumoylationKAKAMQIKVEAFDNE
CEEEEEEEEEECCCC
19.6828112733
350SumoylationNEFEATQKLSSPIDM
CCHHHHHHCCCCCCC
46.0828112733
350UbiquitinationNEFEATQKLSSPIDM
CCHHHHHHCCCCCCC
46.08-
352PhosphorylationFEATQKLSSPIDMTS
HHHHHHCCCCCCCCC
40.8930266825
353PhosphorylationEATQKLSSPIDMTSK
HHHHHCCCCCCCCCH
35.9929255136
358PhosphorylationLSSPIDMTSKRHFEL
CCCCCCCCCHHHHEE
27.6130266825
359PhosphorylationSSPIDMTSKRHFELE
CCCCCCCCHHHHEEC
22.5119691289
360UbiquitinationSPIDMTSKRHFELEK
CCCCCCCHHHHEECC
40.50-
360SumoylationSPIDMTSKRHFELEK
CCCCCCCHHHHEECC
40.5028112733
369PhosphorylationHFELEKHSAPSMVHS
HHEECCCCCCCCCCC
53.6029978859
372PhosphorylationLEKHSAPSMVHSSLT
ECCCCCCCCCCCCCC
32.9029978859
376PhosphorylationSAPSMVHSSLTPFSV
CCCCCCCCCCCCCEE
18.6829978859
377PhosphorylationAPSMVHSSLTPFSVQ
CCCCCCCCCCCCEEE
22.7629978859
379PhosphorylationSMVHSSLTPFSVQVT
CCCCCCCCCCEEEEE
25.0029978859
382PhosphorylationHSSLTPFSVQVTNIQ
CCCCCCCEEEEECCC
16.9129978859
386PhosphorylationTPFSVQVTNIQDWSL
CCCEEEEECCCCCCC
14.9829978859
392PhosphorylationVTNIQDWSLKSEHWH
EECCCCCCCCCCCEE
33.9229978859
394SumoylationNIQDWSLKSEHWHQK
CCCCCCCCCCCEEHH
48.56-
394SumoylationNIQDWSLKSEHWHQK
CCCCCCCCCCCEEHH
48.5628112733
395PhosphorylationIQDWSLKSEHWHQKE
CCCCCCCCCCEEHHH
39.7329978859
401UbiquitinationKSEHWHQKELSGKTQ
CCCCEEHHHHCCCCC
47.97-
401SumoylationKSEHWHQKELSGKTQ
CCCCEEHHHHCCCCC
47.9728112733
406SumoylationHQKELSGKTQNSFKT
EHHHHCCCCCCCEEC
43.4928112733
406SumoylationHQKELSGKTQNSFKT
EHHHHCCCCCCCEEC
43.49-
406UbiquitinationHQKELSGKTQNSFKT
EHHHHCCCCCCCEEC
43.49-
412SumoylationGKTQNSFKTGVVEMK
CCCCCCEECCEEEEC
44.1628112733
412UbiquitinationGKTQNSFKTGVVEMK
CCCCCCEECCEEEEC
44.16-
412SumoylationGKTQNSFKTGVVEMK
CCCCCCEECCEEEEC
44.16-
413PhosphorylationKTQNSFKTGVVEMKD
CCCCCEECCEEEECC
32.9522468782
419UbiquitinationKTGVVEMKDSGYKVS
ECCEEEECCCCCCCC
34.9221906983
419SumoylationKTGVVEMKDSGYKVS
ECCEEEECCCCCCCC
34.9228112733
419SumoylationKTGVVEMKDSGYKVS
ECCEEEECCCCCCCC
34.92-
424SumoylationEMKDSGYKVSDPENL
EECCCCCCCCCHHHC
38.50-
424UbiquitinationEMKDSGYKVSDPENL
EECCCCCCCCCHHHC
38.5021906983
424SumoylationEMKDSGYKVSDPENL
EECCCCCCCCCHHHC
38.5028112733
434SumoylationDPENLYLKQGIANLS
CHHHCHHHHHHHHCC
32.6828112733
434UbiquitinationDPENLYLKQGIANLS
CHHHCHHHHHHHHCC
32.68-
441PhosphorylationKQGIANLSAEVVSLK
HHHHHHCCHHEEEHH
23.3828060719
446PhosphorylationNLSAEVVSLKRLIAT
HCCHHEEEHHHHHHC
33.0928060719
448SumoylationSAEVVSLKRLIATQP
CHHEEEHHHHHHCCC
37.3428112733
448UbiquitinationSAEVVSLKRLIATQP
CHHEEEHHHHHHCCC
37.34-
459PhosphorylationATQPISASDSG----
HCCCCCCCCCC----
26.0628450419
461PhosphorylationQPISASDSG------
CCCCCCCCC------
43.8625159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NFIL3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NFIL3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NFIL3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NC2B_HUMANDR1physical
8836190
MAFF_HUMANMAFFphysical
23661758
BATF_HUMANBATFphysical
23661758
NFIL3_HUMANNFIL3physical
23661758
TRAF2_HUMANTRAF2physical
25416956
AMOL2_HUMANAMOTL2physical
25416956
AMOL2_HUMANAMOTL2physical
21516116
RFWD2_HUMANRFWD2physical
28514442
STK40_HUMANSTK40physical
28514442
CREB1_HUMANCREB1physical
28514442
ATF1_HUMANATF1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NFIL3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-353, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301, AND MASSSPECTROMETRY.

TOP